Poland· PL-100224021
Ranolteril
A tolterodine product containing tolterodini tartras, registered in Poland by Accord Healthcare Polska Sp. z o.o.. The same ATC class is registered in 16 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Tolterodine is registered in 16 of 19 countries.
Countries holding a registration under ATC G04BD07 (tolterodine), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 9 of them publish a price we can compare per daily dose
Tolterodine · ATC G04BD07
16 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of tolterodine costs, country by country.
Normalised to the WHO defined daily dose (4 mg), the median price runs from $0.70 in Italy to $1.95 in Switzerland — a ×2.8 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Tolterodine · price per daily dose (4 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.95
- ES Spain$1.16
- IT Italy$0.70
The record
At a glance
URPL (Poland)- Active substance
- Tolterodini tartras
- Manufacturer
- Accord Healthcare Polska Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- G04BD07
- ATC class
- Tolterodine
- Defined daily dose
- 4 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 13
- gtin05909990769001
- gtin05909990769025
- gtin05909990793198
- gtin05909991059989
- gtin05909991059996
- gtin05909991060008
- gtin05909991060022
- gtin05909991063979
- gtin05909991063955
- gtin05909991063962
- gtin05909991063986
- gtin05909991236281
- gtin05909991236298
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
324 interactions on record for tolterodine.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tolterodine · interactions on record
324 records
- 3 severe
- 129 moderate
- 33 minor
- 152 info
Most severe, free to view
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium chlorideB05XA01severe
- ClotrimazoleA01AB18moderate
7 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Tolterodine in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesDetrolViatris Specialty LLC
- NetherlandsDetrusitol 2 mg, filmomhulde tablettenViatris Healthcare Limited
- SwedenDetrusitol 2 mg Filmdragerad tablettViatris Healthcare Limited
- FinlandDetrusitolViatris Healthcare Limited
- SpainDETRUSITOL 2 mg COMPRIMIDOS RECUBIERTOS CON PELICULAFarmasierra Laboratorios S.L.
- IrelandDetrusitol 2 mg film-coated tabletsViatris Healthcare Limited
- BelgiumDetrusitol 2 mgPI Pharma
- FranceDETRUSITOL 2 mg, comprimé pelliculéVIATRIS UP
Authorised across Europe · EMA
The same active substance is authorised in 23 EEA countries. Names it is sold under:
- Austria · Detrusitol, Tolterodin Accord
- Belgium · Detrusitol, Detrusitol Retard
- Bulgaria · Толтеродин Акорд
- Cyprus · Detrusitol, Tolterana
- Germany · Detrusitol, Detrusitol Retard
- Denmark · Detrusitol Retard, Tolterodin Rivopharm
- Estonia · Uroflow
- Spain · Detrusitol, Detrusitol Neo
- Finland · Detrusitol, Detrusitol Sr
- France · Detrusitol
- United Kingdom (Northern Ireland) · Blerone Xl, Caristenol
- Greece · Cinterol, Detrusitol
- Ireland · Detrusitol, Detrusitol Sr
- Iceland · Detrusitol Retard, Tolterodin Actavis
- Italy · Detrusitol, Detrusitol Retard
- Lithuania · Detrusitol, Detrusitol Sr
- Luxembourg · Detrusitol, Detrusitol Retard
- Latvia · Uroflow
- Netherlands · Detrusitol, Detrusitol Sr
- Norway · Detrusitol Sr, Tolterodine Sandoz
- Romania · Uroflow
- Sweden · Detrusitol, Detrusitol Sr
- Slovenia · Detrusitol
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2fd75f40-626a-469d-8508-db998e5e2287 GET /v1/drugs/2fd75f40-626a-469d-8508-db998e5e2287?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "2 mg",
"packaging": "05909990769001 ¦ Rp ¦ 56851\n14 tabl.\n05909990769025 ¦ Rp ¦ 56852\n28 tabl.\n05909990793198 ¦ Rp ¦ 59415\n56 tabl.\n05909991059989 ¦ Rp ¦ Skasowane ¦ 84058\n20 tabl.\n05909991059996 ¦ Rp ¦ Skasowane ¦ 84059\n30 tabl.\n05909991060008 ¦ Rp ¦ Skasowane ¦ 84060\n60 tabl.\n05909991060022 ¦ Rp ¦ Skasowane ¦ 84061\n90 tabl.\n05909991063979 ¦ Rp ¦ 84290\n60 tabl.\n05909991063955 ¦ Rp ¦ 84397\n20 tabl.\n05909991063962 ¦ Rp ¦ 84398\n30 tabl.\n05909991063986 ¦ Rp ¦ 84400\n90 tabl.\n05909991236281 ¦ Rp ¦ 110655\n50 tabl.\n05909991236298 ¦ Rp ¦ Skasowane ¦ 110656\n100 tabl.",
"substance": "Tolterodini tartras 2 mg",
"common_name": "Tolterodini tartras",
"pl_product_id": "100224021",
"pozwolenie_nr": "16422",
"auth_procedure": "DCP",
"authorisation_validity": "2025-01-31"
}See everything about tolterodine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.